Monographie - Ceftaroline fosamil - Stabilis 4.0

最新更新 :
14/02/2025

抗生素

Ceftaroline fosamil

注射液

溶液稳定性

混合物稳定性

影响稳定性的因素

兼容性

用药途径

引用文献

PDF

化学式

商品名

商品名

商品名仅供参考, 药品所用的辅料可能依国家或厂商不同有所不同。

Zinforo

克罗地亚, 冰岛, 匈牙利, 卢森堡, 墨西哥, 巴西, 德国, 意大利, 挪威, 斯洛文尼亚, 比利时, 法国, 澳大利亚, 爱尔兰, 瑞典, 瑞士, 突尼斯, 罗马尼亚, 芬兰, 英国, 西班牙, 阿根廷, 马来西亚

引用文献

注射液

引用文献 : Ceftaroline fosamil

	种类	出版物
3249	文献	Singh BM, Dedhiya MG, Dinunzio J, Chan P, Kupiec TC, Trissel LA, Laudano JB. Compatibility of ceftaroline fosamil for injection with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 2011 ; 68: 2163-2169.
3520	实验室	Cidomycin - Summary of product Chracteristics. Sanofi 2011
3549	实验室	Amikacine B Braun - Résumé des caractéristiques du produit. B Braun 2012
3643	实验室	Gentamicin sulphate (Cidomycin®) - Summary of Product Characteristics Sanofi 2015
3674	实验室	Erythromycin lactobionate - Summary of Product Characteristics PanPharma 2016
3812	文献	Bhattacharya S, Parekh S, Dedhiya M. In-use Stability of Ceftaroline Fosamil in Elastomeric Home Infusion Systems and MINI-BAG Plus Containers. Int J Pharm Compound 2015 ; 19, 5 : 432-436.
3827	海报	Ghazi I.M, Hamada Y, Nicolau D.P. Compatibility of tedizolid phosphate with selected intravenous drugs via simulated Y-site conditions. ASHP Midyear 2015
3828	海报	Thabit A.K, Hamada Y, Nicolau D.P. Ceftozolane/tazobactam physical compatibility during simulated Y-site administration. ASHP Midyear 2015
3829	海报	So W, Kim L, Thabit A.K, Nicolau D.P, Kuti J.L. Compatibility of isavunazonium sulfate during simulated Y-site administration. ASHP Midyear 2015
4055	文献	Monogue M, Almarzoky Abuhussain S, Kuti J, Nicolau D. Physical compatibility of fosfomycin for injection with select i.v. drugs during simulated Y-site administration. Am J Health-Syst Pharm 2018 , 75, 1:36-44
4059	文献	Madfai F, Zaidi S, Ming L, Wanandy T, Patel R. Physical and chemical stability of ceftaroline in an elastomeric infusion device. EJHP 2017 ; 25, e2
4145	文献	Asempa T.E, Avery L.M, Kidd J.M, Kuti J.L, Nicolau D.P. Physical compatibility of plazomicin with select i.v. drugs during simulated Y-site administration. Am J Health-Syst Pharm 2018 ;75,14:1048-1056
4434	文献	Avery L.M, Chen, I.H, Reyes, S, Nicolau, D.P, Kuti J.L. Assessment of the Physical Compatibility of Eravacycline and Common Parenteral Drugs During Simulated Y-site Administration. Clin Ther 2019 ; 41, 10: 2162-2170.
4528	文献	Lu J, Liu Q, Kupiec T, Vail H, Lunch L, Fam D, Vu N. Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration. Int J Pharm Compound 2021 ;25,1:52-61
4801	文献	Ruiz V, Yuwei Shen Y, Abouelhassan Y, Fouad A, Nicolau D, Kuti J. Physical compatibility of sulbactam/durlobactam with select intravenous drugs during simulated Y-site administration. Am J Health-Syst Pharm 2024 ;51,1:

Mentions Légales